Evidence-based recommendations on Endocuff Vision for assisting visualisation during colonoscopy.
The scope of this evaluation included patients having colonoscopies as part of the NHS bowel cancer screening programme. The UK National Screening Committee is responsible for deciding if new technologies, such as Endocuff Vision, are formally incorporated into screening pathways. The screening programme is covered by service specification number 26. Service specifications are updated each year using a published process.
NICE has developed tools, in association with relevant stakeholders, to help organisations put this guidance into practice.
Next review: 2022
NICE medical technologies guidance addresses specific technologies notified to NICE by sponsors. The ‘case for adoption’ is based on the claimed advantages of introducing the specific technology compared with current management of the condition. This case is reviewed against the evidence submitted and expert advice. If the case for adopting the technology is supported, then the technology has been found to offer advantages to patients and the NHS. The specific recommendations on individual technologies are not intended to limit use of other relevant technologies which may offer similar advantages.